New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy.

Yang, Jingmin; Chen, Yanying; Li, Xiao; Xu, Danyan

Yang, Jingmin; Chen, Yanying; Li, Xiao; Xu, Danyan.

Afiliação

Yang J; Department of Cardiology, The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, 410000, Hunan, China.
Chen Y; Department of Cardiology, The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, 410000, Hunan, China.
Li X; Department of Cardiology, The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, 410000, Hunan, China.
Xu D; Department of Cardiology, The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, 410000, Hunan, China. xudanyan02@csu.edu.cn.

Heart Fail Rev ; 27(4): 1431-1441, 2022 07.

Article em En | MEDLINE | ID: mdl-34455516

Assuntos

11-beta-Hidroxiesteroide Desidrogenase Tipo 1; Glucocorticoides; 11-beta-Hidroxiesteroide Desidrogenase Tipo 1/metabolismo; Cardiomegalia; Glucocorticoides/metabolismo; Glucocorticoides/farmacologia; Glucocorticoides/uso terapêutico; Coração; Humanos; Miocárdio/metabolismo

Palavras-chave

11ß-hydroxysteroid dehydrogenases (11ß-HSDs); Glucocorticoid receptor (GR); Glucocorticoids (GCs); Mineralocorticoid receptor (MR); Pathological cardiac hypertrophy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: 11-beta-Hidroxiesteroide Desidrogenase Tipo 1 / Glucocorticoides Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google